Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 111Neoplasm Metastasis 9Neoplasms 5Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms, Male 3Breast Diseases 3Obesity 2Multiple Endocrine Neoplasia Type 1 2Endometrial Neoplasms 2Breast Cancer Metastatic 2Arthralgia 2Triple Negative Breast Neoplasms 1Thoracic Neoplasms 1Sleep Wake Disorders 1Skin Diseases 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Prostatic Neoplasms 1Primary Breast Cancer ER+ve 1Post Menopausal Women With Early Breast Cancer 1Patient Acceptance of Health Care 1Pain 1Ovarian Neoplasms 1Neoplasms by Site 1Metastatic Beast Cancer 1Mammary Neoplasms, Animal 1Lymphoma 1Lung Neoplasms 1Lung Diseases 1Lethal Congenital Contracture Syndrome 2 1

Interventions

Fulvestrant 5Anastrozole 4Letrozole 3Docetaxel 2Dasatinib 2vandetanib 1sonidegib 1ribociclib 1pembrolizumab 1palbociclib 1olaparib 1irinotecan sucrosofate 1exemestane 1cediranib 1XMT-1522 1Vorinostat 1Tablets 1Ritonavir 1Population Groups 1Paclitaxel 1Moxifloxacin 1Itraconazole 1Histone Deacetylase Inhibitors 1Gemcitabine 1FCN-437c 1Everolimus 1Electroporation 1Cryosurgery 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Breast Cancer × exemestane × Clear all
NCT02069093 2017-02-13

Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer

Novartis

Phase 2 Completed
92 enrolled 9 charts
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡